Skip to main content
ADMA logo
ADMA
(NASDAQ)
ADMA Biologics, Inc.
$8.21-- (--)
Loading... - Market loading

ADMA Biologics (ADMA) Stock Price & Financial Analysis

ADMA Biologics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$8.17 - $8.38
52-Week High$22.20
52-Week Low$7.21
Open$8.29
Volume3.02M
Average Volume (3M)5.51M
Market Cap2.07B
Shares Outstanding243.85M
P/E Ratio (TTM)14.07
Forward P/E18.70
Price to Sales (P/S)4.05
Price to Book (P/B)4.33
EV/EBITDA10.44
Revenue (TTM)510.17M
Net Income (TTM)146.93M
Free Cash Flow (TTM)27.70M
EPS (TTM)$0.60
Profit Margin28.80%
Operating Margin37.52%
Return on Equity (ROE)30.78%
Debt to Equity0.17
50-Day MA$9.26
200-Day MA$14.54
52-Week Change-61.96%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About ADMA Biologics

What is the current stock price for ADMA?

As of the latest trading session, ADMA stock trades at $8.21. The 52-week range is $7.21–$22.20, with a day range of $8.17–$8.38.

What is the P/E ratio for ADMA?

ADMA Biologics's trailing P/E ratio is 14.1, meaning investors pay $14.1 for every $1 of annual earnings. The forward P/E is 18.7, reflecting analyst expectations for future earnings. ADMA Biologics operates in the Healthcare sector.

Does ADMA pay dividends?

ADMA Biologics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ADMA?

Based on 3 analysts, the consensus for ADMA is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of ADMA?

ADMA Biologics's market capitalization is $2.00B, classifying it as a mid-cap company. ADMA Biologics operates in the Healthcare sector within the Biotechnology industry.